Extraction of Human Epidermis Treated with Retinol Yields Retro-Retinoids in Addition to Free Retinol and Retinyl Esters

Vitamin A, all-trans-retinol, is metabolized to retinoic acid in vivo by a tightly controlled two-step conversion. Retinoic acid then binds to nuclear receptors and modulates cellular proliferation and differentiation. Because only a small fraction of retinol applied topically can be metabolized to...

Full description

Saved in:
Bibliographic Details
Published inJournal of investigative dermatology Vol. 107; no. 2; pp. 178 - 182
Main Authors Duell, Elizabeth A., Kang, Sewon, Elder, James T., Voorhees, John J., Derguini, Fadila
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.1996
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Vitamin A, all-trans-retinol, is metabolized to retinoic acid in vivo by a tightly controlled two-step conversion. Retinoic acid then binds to nuclear receptors and modulates cellular proliferation and differentiation. Because only a small fraction of retinol applied topically can be metabolized to retinoic acid, alternative pathways of retinol metabolism in skin were investigated. Retinol (0.4%) was applied to adult human skin under occlusion for 6h to 4 d. The conversion of retinal into various metabolites such as 14-hydroxy-4,14-retro-retinol, anhydroretinol, 4-oxoretinol, retinyl esters, and retinyl glucuronides was investigated. The level of 14-hydroxy-retro-retinol was increased from undetectable at time 0 to 326ng/g wet weight of tissue at 6h (6% of the retinol level) and maintained approximately the same concentration at 24h to 409ng/g wet weight (1.9% of the retinol level); it decreased to 48ng/g wet weight of tissue (12% of its maximum level) by 4 d. Anhydroretinol was undetectable at time 0, increased only slightly at 6 h, and remained at the same level. We did not detect 4-oxoretinol. Because 14-hydroxy-retro-retinol was found in the retinol-treated areas, its effects on epidermis were compared with those of retinol. Topical application of trans-retinol (0.3%) significantly increased both epidermal thickness and cellular retinoic acid binding protein II mRNA, whereas 14-hydroxy-4,14-retro-retinol (0.3%) did not increase either of these well-characterized cutaneous retinoid responses. Retinol, when applied topically in pharmacologic doses to human epidermis, remained as free retinol, was metabolized primarily to retinol ester, and was metabolized to a lesser extent to retro-retinoids and didehydroretinol.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-202X
1523-1747
DOI:10.1111/1523-1747.ep12329576